- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Boehringer Ingelheim appoints Harsha Deshmukh to its Board of Managing Directors

Ingelheim: Boehringer Ingelheim has announced that the Shareholders' Committee has appointed Harsha Deshmukh to the Board of Managing Directors. effective 1 February 2026.
Harsha Deshmukh will lead the IT and Global Business Services functions focusing on digital transformation and driving the further development of business services at the company. IT and Global Business Services, which so far were part of the Group Functions Division, will be set up as a separate Board Division.
Commenting on the appointment, Hubertus von Baumbach, Chairman of the Boehringer Shareholders’ Committee said, “We warmly welcome Harsha Deshmukh. With his extensive experience in fostering innovation, he will help drive our journey of transformation – a transformation in the interest of patients. We know that in this process of continuous improvement we can rely on the proven skills, the contributions and the high commitment of each individual in our organization.”
Chairman of the Board of Managing Directors Shashank Deshpande added, “I am excited to welcome Harsha to Boehringer Ingelheim. His appointment strengthens our capabilities in the important segments of IT and services, two areas that are critical elements to underpin our future growth.”
Harsha Deshmukh will join Boehringer Ingelheim from Infineon Technologies AG in Munich, where he most recently was Executive Vice President & Chief Information Officer. He holds degrees in Electronics, Human Resources and Global Management from the University of Mumbai, Babson College and INSEAD.
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health.
Read also: Boehringer Ingelheim obtains two EU CVMP positive opinions for avian influenza vaccines
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

